Effects of treatment with non-immersive virtual reality in the quality of life of people with Parkinson's disease

This research aimed to investigate the effects of treatment with non-immersive virtual reality in the quality of life of individuals with Parkinson's disease before and after treatment with the questionnaire of Parkinson's disease PDQ-39. It corresponds to an experimental study, quantitative, of uncontrolled clinical trial type. It involved 14 individuals who underwent 20 individual treatment sessions divided into two weekly sessions lasting 30 to 40 minutes each. In the data analysis, the Wilcoxon test was used to find the value of statistical significance p = 0.05. The scores of Questionnaire Parkinson's disease-39 overall and its domains decreased when compared to the evaluation period and the revaluation of patients. However, p values express that this decrease was significant if specific areas for mobility, emotional well-being, stigma and cognition, and the Questionnaire score of Parkinson's Disease-39 overall. Thus, the results demonstrated that non-immersive virtual reality contributed positively on the quality of life of these individuals.本研究旨在采用帕金森病（Parkinson's disease）生活质量问卷39项（PDQ-39），探究非沉浸式虚拟现实（non-immersive virtual reality）治疗对帕金森病患者治疗前后生活质量的影响。本研究属于非对照临床试验类别的定量实验研究，共纳入14名受试者，受试者需完成20次单次治疗疗程，治疗频次为每周2次，每次时长30至40分钟。数据分析阶段采用Wilcoxon检验（Wilcoxon test），设定统计学显著性阈值p=0.05。相较于基线评估与后续复测结果，帕金森病患者的PDQ-39量表总分及其各维度得分均有所下降，但经检验，该下降在运动功能、情绪健康、病耻感与认知功能等特定维度，以及PDQ-39量表总分上均具有统计学显著性。综上，研究结果表明非沉浸式虚拟现实治疗可对帕金森病患者的生活质量产生积极影响。